Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP258189.RALeUpRe8IDR_tm-KB2kQeHquLKKAD1aQVzSuet5aW2SA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP258189.RALeUpRe8IDR_tm-KB2kQeHquLKKAD1aQVzSuet5aW2SA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP258189.RALeUpRe8IDR_tm-KB2kQeHquLKKAD1aQVzSuet5aW2SA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP258189.RALeUpRe8IDR_tm-KB2kQeHquLKKAD1aQVzSuet5aW2SA130_provenance.
- NP258189.RALeUpRe8IDR_tm-KB2kQeHquLKKAD1aQVzSuet5aW2SA130_assertion description "[We now show that cancer cells that have acquired resistance to single-target EGFR inhibitors through upregulation of AXL or loss of E-cadherin remain sensitive to CUDC-101, which inhibits MET- and AXL-mediated signaling, restores E-cadherin expression, and reduces cell migration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP258189.RALeUpRe8IDR_tm-KB2kQeHquLKKAD1aQVzSuet5aW2SA130_provenance.
- NP258189.RALeUpRe8IDR_tm-KB2kQeHquLKKAD1aQVzSuet5aW2SA130_assertion evidence source_evidence_literature NP258189.RALeUpRe8IDR_tm-KB2kQeHquLKKAD1aQVzSuet5aW2SA130_provenance.
- NP258189.RALeUpRe8IDR_tm-KB2kQeHquLKKAD1aQVzSuet5aW2SA130_assertion SIO_000772 23536719 NP258189.RALeUpRe8IDR_tm-KB2kQeHquLKKAD1aQVzSuet5aW2SA130_provenance.
- NP258189.RALeUpRe8IDR_tm-KB2kQeHquLKKAD1aQVzSuet5aW2SA130_assertion wasDerivedFrom befree-20150227 NP258189.RALeUpRe8IDR_tm-KB2kQeHquLKKAD1aQVzSuet5aW2SA130_provenance.
- NP258189.RALeUpRe8IDR_tm-KB2kQeHquLKKAD1aQVzSuet5aW2SA130_assertion wasGeneratedBy ECO_0000203 NP258189.RALeUpRe8IDR_tm-KB2kQeHquLKKAD1aQVzSuet5aW2SA130_provenance.
- befree-20150227 importedOn "2015-02-27" NP258189.RALeUpRe8IDR_tm-KB2kQeHquLKKAD1aQVzSuet5aW2SA130_provenance.